Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Muggia

Showing results (301-310 of 317) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study GroupN Petrelli, H O Douglass, L Herrera, et al.
Journal of Biological Response Modifiers|August 1, 1988
Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposideR L Krigel, C M Slywotzky, M Lonberg, et al.
Gynecologic Oncology|May 1, 1997
Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot studyL I Muderspach, J P Curtin, L D Roman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group studyC G Leichman, T R Fleming, F M Muggia, et al.
Cancer Research|May 1, 1988
Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferonM D Green, J L Speyer, H S Hochster, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
The disposition of carboplatin in ovarian cancer patientsR C Gaver, N Colombo, M D Green, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Cisplatinumdiamminodichloride (CPDD) in chemotherapy of cancers: a phase II therapeutic trialM Hayat, G Brulé, P Cappelaere, et al.
Psycho-Oncology|August 29, 2000
Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trialC M Moinpour, J Sawyers Triplett, B McKnight, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|December 1, 1991
Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experienceE M Hersh, B S Metch, F M Muggia, et al.
Gynecologic Oncology|June 1, 1996
Intraperitoneal mitoxantrone or floxuridine: effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy--a randomized phase II study by theSouthwest Oncology GroupF M Muggia, P Y Liu, D S Alberts, et al.
Pageof 32

Showing results (301-310 of 317) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study GroupN Petrelli, H O Douglass, L Herrera, et al.
Journal of Biological Response Modifiers|August 1, 1988
Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposideR L Krigel, C M Slywotzky, M Lonberg, et al.
Gynecologic Oncology|May 1, 1997
Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot studyL I Muderspach, J P Curtin, L D Roman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group studyC G Leichman, T R Fleming, F M Muggia, et al.
Cancer Research|May 1, 1988
Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferonM D Green, J L Speyer, H S Hochster, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
The disposition of carboplatin in ovarian cancer patientsR C Gaver, N Colombo, M D Green, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Cisplatinumdiamminodichloride (CPDD) in chemotherapy of cancers: a phase II therapeutic trialM Hayat, G Brulé, P Cappelaere, et al.
Psycho-Oncology|August 29, 2000
Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trialC M Moinpour, J Sawyers Triplett, B McKnight, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|December 1, 1991
Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experienceE M Hersh, B S Metch, F M Muggia, et al.
Gynecologic Oncology|June 1, 1996
Intraperitoneal mitoxantrone or floxuridine: effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy--a randomized phase II study by theSouthwest Oncology GroupF M Muggia, P Y Liu, D S Alberts, et al.
Pageof 32